|
SEC11A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.045200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.531600E-01 |
| Normal-vs-Stage2 |
8.242400E-01 |
| Normal-vs-Stage3 |
3.158400E-02 |
| Normal-vs-Stage4 |
1.967630E-01 |
| Stage1-vs-Stage2 |
7.033400E-01 |
| Stage1-vs-Stage3 |
8.431900E-04 |
| Stage1-vs-Stage4 |
3.944000E-02 |
| Stage2-vs-Stage3 |
5.681800E-02 |
| Stage2-vs-Stage4 |
2.126400E-01 |
| Stage3-vs-Stage4 |
6.087400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.664600E-01 |
| Normal-vs-AfricanAmerican |
4.437000E-01 |
| Normal-vs-Asian |
7.600200E-01 |
| Caucasian-vs-AfricanAmerican |
7.096400E-01 |
| Caucasian-vs-Asian |
5.640800E-01 |
| AfricanAmerican-vs-Asian |
4.585600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.696800E-01 |
| Normal-vs-Female |
5.931000E-01 |
| Male-vs-Female |
8.348800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.824400E-01 |
| Normal-vs-Age(41-60Yrs) |
5.712000E-01 |
| Normal-vs-Age(61-80Yrs) |
9.039800E-01 |
| Normal-vs-Age(81-100Yrs) |
2.905600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.441200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.691000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.507600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.858200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.709600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.614400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.726400E-01 |
| Normal-vs-Grade 2 |
2.911400E-01 |
| Normal-vs-Grade 3 |
2.303400E-01 |
| Normal-vs-Grade 4 |
1.166450E-02 |
| Grade 1-vs-Grade 2 |
8.958000E-01 |
| Grade 1-vs-Grade 3 |
3.974400E-01 |
| Grade 1-vs-Grade 4 |
2.513800E-02 |
| Grade 2-vs-Grade 3 |
4.139800E-03 |
| Grade 2-vs-Grade 4 |
5.159500E-04 |
| Grade 3-vs-Grade 4 |
6.488300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.632210E-01 |
| Normal-vs-ccB subtype |
1.166560E-01 |
| ccA subtype-vs-ccB subtype |
6.794200E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.711800E-01 |
| Normal-vs-N1 |
4.586600E-01 |
| N0-vs-N1 |
3.957000E-01 |
|
|
